Thanks to some crafty payer negotiating from GSK, even if Advair generics win approval, it may be a while before they gain serious traction, even if it wins…

Sanofi and Swiss contractor Lonza will share the cost of building a €270 million ($286.3 million) plant to expand capacity for new biologic meds.

A North Carolina company that makes transdermal patches has gotten an FDA warning letter for releasing subpotent transdermal pain patches.

Contract manufacturer Fareva has completed an aerosol plant in Virginia but is considering a second upgrade that would more than double capacity at the…

Sanofi is jumping into the Rituxan biosimilars fray in a potential $200 million-plus deal with JHL Biotech, putting the Taiwan-based drugmaker's new China…

Valeant's business relationships with its distributors are under scrutiny once again, with the latest probe focusing on the remarkable sales performance…

The massive CPhI show kicked off in Barcelona, Spain, on Tuesday with numbers that rival some small cities. An estimated 38,000 visitors from 150 countries…

Pamplona, Spain-based Idifarma announced Monday that Suanfarma, an API producer based in Madrid, had bought out some of the venture capital investors who…

Partnering